Your browser doesn't support javascript.
loading
Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression.
Li, Xiang; Gohain, Neelakshi; Chen, Si; Li, Yinghua; Zhao, Xiaoyuan; Li, Bo; Tolbert, William D; He, Wangxiao; Pazgier, Marzena; Hu, Honggang; Lu, Wuyuan.
Afiliação
  • Li X; School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
  • Gohain N; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Chen S; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Li Y; School of Medicine, Shanghai University, Shanghai 200444, China.
  • Zhao X; Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
  • Li B; Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
  • Tolbert WD; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
  • He W; State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
  • Pazgier M; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Hu H; Department of Talent Highland, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Lu W; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Acta Pharm Sin B ; 11(9): 2655-2669, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34589387

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Acta Pharm Sin B Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Acta Pharm Sin B Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China